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Letter to the Editor 
Change over time of COVID-19 hospital presentation in Northern Italy      
After the first autochthonous case described on February 19, also in 
Italy the Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS- 
CoV-2) infection rapidly circulated, mainly in the Northern regions of 
the country. The earliest reports on Coronavirus disease-19 (COVID-19) 
have described worldwide a high prevalence of severe respiratory ill-
ness [1]. A suggestive feature of COVID-19 has been a rapid progression 
of the respiratory impairment, leading to acute respiratory distress 
syndrome (ARDS) and often requiring ventilation support [2]. To date, 
whether clinical features at hospital presentation and outcome of 
COVID-19 have changed over the outbreak course is unknown. We 
explored this issue in a multicenter cohort of patients hospitalized for 
COVID-19 in Northern Italy. 
We retrospectively revised the clinical records of all consecutive 
patients admitted for SARS-CoV-2 infection between March 1 and May 
12, 2020 in three hospitals of the Piedmont region: “Maggiore della 
Carità Hospital” in Novara, “Sant'Andrea” Hospital, in Vercelli, “Santi 
Antonio e Biagio e Cesare Arrigo” Hospital, in Alessandria. These hos-
pitals are the referral of a large homogenous territory in Eastern 
Piedmont, one of the most hit by the SARS-CoV-2 pandemic [3]. The 
study protocol was approved by the institutional ethical committee of 
Novara (IRB code CE 97/20). For the purpose of the analysis, we di-
vided the whole study duration in two time spans: period 1 (from March 
1 to April 13, i.e. during the maximal diffusion of SARS-CoV-2 infec-
tion) and period 2 (from April 14 to May 12, during the declining in-
fection). The starting of period 2 was set on April 14 as this date re-
presented the turning point when the increase in the daily number of 
individuals positive for SARS-CoV-2 infection in Piedmont has ceased  
[3]. Informed consent was waived due to the retrospective nature of the 
study and use of pseudonymized data. 
The following endpoints were compared between patients admitted 
in the two abovementioned periods:  
1. Incidence of patients requiring mechanical ventilation on the day of 
admission.  
2. Incidence of patients with severe ARDS on the day of admission. 
Severe ARDS was defined according to the Berlin definition [4].  
3. A score indicative of critical COVID-19 on the day of admission. 
Patients were stratified according to the Shang's score, which re-
presents a clinical classification of COVID-19 severity, as per recent 
description in a cohort of patients diagnosed with SARS-CoV-2 in-
fection in Wuhan (China) [5]. Patients with score of critical disease 
were identified as those with respiratory failure requiring 
mechanical ventilation or with shock or other organ failure re-
quiring Intensive Care Unit monitoring and treatment. 
The daily percentage of patients with mechanical ventilation, severe 
ARDS and a score of critical disease on admission was obtained from the 
daily number of each outcome measure on admission and the total 
number of patients hospitalized in the same day. This was recorded for 
all 44 days of period 1 and 29 days of period 2. Incidence rate ratios 
(IRR) comparing period 1 and period 2 were calculated using Poisson 
regression. The weekly number of events per 100 patients was re-
presented in a plot together with a Local polynomial regression 
smoothing curve. A span smoothing control of 0.75 with 2 degrees of 
the polynomials has been considered for the computation. The R2 
model fitting statistics was also computed. 
A total of 522 patients were overall included in this analysis, 416 
admitted from March 1 to April 13 (period 1) and 106 from April 14 to 
May 12 (period 2). Main characteristics of the two groups are indicated 
in Table 1. Patients hospitalized in the later phase of the SARS-CoV-2 
outbreak were older and had a lower prevalence of male gender and 
diabetes mellitus. In period 2, cough, dyspnea and sputum production 
were less represented as clinical features upon Emergency Department 
presentation, body temperature was lower, and levels of C-reactive 
protein tended to be reduced. In the later phase patients were less 
frequently treated with hydroxychloroquine, lopinavir/ritonavir and 
tocilizumab. 
Mean IR of mechanical ventilation on admission was 5.0 per 100 
patient-days in period 1 and 0.6 per 100 patient-days in period 2; IR of 
severe ARDS on admission was 12.9 per 100 patient-days and 2.3 per 
100 patient-days, respectively. For both these outcome measures, the 
rates in period 2 were significantly lower compared to period 1 (IRR of 
mechanical ventilation 0.11, 95% CI 0.07-0.19; p=0.0001; IRR of se-
vere ARDS 0.18, 95% CI 0.14-0.23; p=0.0001) (Fig. 1). The occurrence 
of a score on the day of admission indicating a critical COVID-19 was 
11.1 per 100 patient-days in period 1 and 2.6 per 100 patient-days in 
period 2, with a significant 65% relative reduction in the latter time 
span (IRR 0.35, 95% CI 0.26-0.48; p=0.0001) (Fig. 1). As patients 
admitted in the later phase were older, we performed a sensitivity 
analysis in the subgroup with age ≥70 years, where consistent results 
on the event rates upon hospitalization were observed in period 2 vs 1: 
mechanical ventilation: OR 0.27, 95% CI 0.03-2.10; severe ARDS: OR 
0.39, 95% CI 0.20-0.79; score of severe disease: OR 0.24, 95% CI 0.05- 
1.02. Fig. 2 depicts the weekly course of total number of 
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hospitalizations, percentage of mechanical ventilations, percentage of 
severe ARDS and percentage of patients with a score of severe disease 
across the two periods. 
In this observational, retrospective, multicenter investigation on 
consecutive patients admitted for COVID-19 we found that with de-
creasing viral diffusion the severity of the respiratory tract involvement 
and the inflammatory status at hospital presentation were less pro-
nounced, as demonstrated by a fewer prevalence of cough, dyspnea and 
sputum production, as well as by a lower body temperature and a trend 
towards reduced C-reactive protein levels. As a consequence, in the 
later phase we observed an 89% relative reduction in the incidence rate 
of mechanical ventilation on admission and an 82% relative reduction 
of early severe ARDS. A clinical score on admission indicating a critical 
COVID-19 was also less frequently observed in period 2, with a 65% 
relative reduction. During the SARS-CoV-2 outbreak we report a linear 
decrease over time of severe ARDS and mechanical ventilation use 
(Fig. 2). In fact, the incidence of both these parameters was highest in 
the first 3 weeks of period 1, i.e. when the total number of cases and 
hospitalizations was still low, and continued to decrease in the sub-
sequent 3 weeks of period 1, while the total number of cases and hos-
pitalizations was increasing. Nevertheless, the percentage of patients 
with a score of critical disease tended to increase in the first weeks of 
period 1, concomitantly with the increase in the number of hospitali-
zations; this apparent inconsistency may be due to the hospital over-
crowding and limited bed capacity in the intensive care units  that 
occurred at the beginning of the epidemic in Northern Italy, when se-
vere cases with less life expectancy were not intubated. Notably, period 
1 almost entirely refers to the time of national lock-down, decreed on 
March 8th, characterized by strict social containing measures and lim-
itation of several economic activities. 
The present study has strengths and limitations. It was performed 
comparing clinical features upon hospital presentation and outcome of 
COVID-19 over two subsequent periods in consecutive patients from the 
same area, receiving consistent in-hospital protocols of diagnosis or 
care and managed by the same care-workers. Our investigation has 
limitations inherent to observational and retrospective studies, mainly 
the risk of residual confounding. Individual data were accurately col-
lected with a strict source verification for the event adjudication; 
however, the retrospective design and the conduction of the study 
during a National Emergency contributed to the lack of some, although 
limited, data, which were not available. Furthermore, data on COVID- 
19 patients who died before the Emergency Department presentation 
were not available. A selection bias may exist, as it is reasonable that 
the wider diffusion of the outbreak in the earlier period led to admit to 
the hospital only those patients with more critical clinical pictures. 
Finally, whether our results may also apply to regions with lower viral 
circulation or different health-care systems it is unknown. Actually, the 
exponential increase of COVID-19 cases at the beginning of the epi-
demic heavily affected the sustainability of hospital acceptance capa-
city, limiting hospitalization to more severe cases. 
In conclusion, this investigation indicates a progressive decreasing 
severity of COVID-19 at hospital presentation over the pandemic period 
in Northern Italy. In particular, the percentage of patients with early 
severe ARDS or requiring early mechanical ventilation was significantly 
reduced. We believe these findings may be relevant, as large areas in 
the world are fully involved in the SARS-CoV-2 pandemic yet and may 
represent the basis for further evaluations by epidemiologists and vir-
ologists. It is reasonable that the wider diffusion of the outbreak in the 
earlier period led to admit to the hospital only those patients with 
critical clinical pictures. However, our findings might support that, 
during the intense virus circulation, expositions to a higher viral load or 
re-expositions have caused more severe disease presentations [6]; in-
deed, the relationship between viral load and COVID-19 severity is 
controversial, with recent data showing no significant difference in the 
viral load of symptomatic versus asymptomatic patients with SARS- 
CoV-2 infection [7]. Specific studies are needed to investigate this latter 
issue, as well as to explore whether our results can be also due to a 
decrease over time in the virulence of SARS-CoV-2, linked to intrinsic 
(i.e. virus mutations) and/or extrinsic (i.e. environmental) mechanisms. 
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Table 1 
Main characteristics of patients admitted in the two time periods of the SARS- 
CoV-2 infection.       
Period 1 (March 1 
to April 13)  
N=416 
Period 2 (April 14 
to May 12) N=106 
p value  
Age (years) 67.5 ± 15 73.1 ± 16.7 0.001 
Male gender 255 (61.3) 51 (48.5) 0.015 
Obesity* 87 (31.4) 16 (20.3) 0.07 
Arterial hypertension 241 (57.9%) 56 (52.8) 0.38 
Diabetes mellitus 125 (30) 16 (15) 0.002 
Cardiomyopathy 107 (25.7) 23 (21.7) 0.45 
Chronic obstructive 
pulmonary disease 
70 (16.8) 14 (13.2) 0.38 
Chronic renal failure 66 (15.9) 24 (22.6) 0.10 
History of cancer 110 (26.4) 27 (25.4) 0.90 
Chronic liver disease 12 (2.9) 6 (5.7) 0.23 
Autoimmune diseases 33 (7.9) 6 (5.7) 0.54 
Symptoms upon presentation    
Cough or dyspnea 232 (55.8) 43 (40.6) 0.006 
Sputum production 49 (11.8) 2 (1.9) 0.002 
Chest pain 53 (12.7) 5 (4.7) 0.023 
Syncope 21 (5.1) 4 (3.7) 0.63 
Clinical signs upon 
presentation    
Systolic blood pressure 
(mmHg) 
127 ± 21 130 ± 24 0.20 
Body temperature (°C) 37.5 ± 1.0 37.1 ± 1.1 0.001 
Heart rate (bpm) 86 ± 17 87 ± 22 0.68 
C-reactive protein (mg/dL) 8.6 ± 7.5 7.3 ± 6.1 0.12 
In-hospital therapy    
Hydroxychloroquine* 325 (89.0) 73 (80.2) 0.034 
Lopinavir/ritonavir 70 (16.8) 5 (4.7) 0.002 
Remdesivir 8 (1.9) 0 0.22 
Tocilizumab 45 (10.8) 1 (0.9) 0.002 
Low molecular weight 
heparin* 
286 (78.4) 84 (85.7) 0.12 
Data are expressed as n (%) or mean ± standard deviation. * Data were missing 
for obesity in 166 patients (139 in period 1 and 27 in period 2), for hydroxy-
chloroquine in 66 patients (51 in period 1 and 15 in period 2) and for low 
molecular weight heparin in 59 patients (51 in period 1 and 8 in period 2).  
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Fig. 1. Forrest plot comparing the IRR of mechanical ventilation, severe ARDS and a clinical score of critical disease on admission in period 2 (from April 14 to May 
12, 2020) vs period 1 (from March 1 to April 13, 2020). 
ARDS= Acute Respiratory Distress Syndrome; IRR= incidence rate ratio 
Fig. 2. Local Polynomial Regression smoothing (LOESS) plots. 
Panel A: Total hospitalizations; a LOESS smoothing method has been considered for the analysis with a degree of non-linear approximation (span) of 0.75. R2=0.88. 
Panel B: Weekly number of patients with mechanical ventilation over number of hospitalizations; a LOESS smoothing method has been considered for the analysis 
with a degree of non-linear approximation (span) of 0.75. R2=0.75. Panel C: Weekly number of patients with severe ARDS over number of hospitalizations; a LOESS 
smoothing method has been considered for the analysis with a degree of non-linear approximation (span) of 0.75. R2=0.8. Panel D: Weekly number of patients with 
a clinical score of severe COVID-19 over number of hospitalizations; a LOESS smoothing method has been considered for the analysis with a degree of non-linear 
approximation (span) of 0.75. R2=0.6. 
ARDS= Acute Respiratory Distress Syndrome 
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